CSIMarket
 


Sage Therapeutics Inc   (SAGE)
Other Ticker:  
 

Sage Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Sage Therapeutics Inc in the third quarter 2023?
Sage Therapeutics Inc recorded a cumulative net loss of $-656 million during 12 months ending in the third quarter 2023, resulting in a negative return on equity (ROE) of -62.67%.

Within the Major Pharmaceutical Preparations industry 219 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2023 from 3234 to 3237.

What is ROE?



Return On Equity (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change -40.83 % -34.56 % -29.99 % -27.55 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -656 -592 -558 -533 -510
Return On Equity (TTM) -62.67 % -49.82 % -42.32 % -37.03 % -32.76 %
SAGE's Total Ranking # 3237 # 3234 # 1410 # 0 # 0
Equity (TTM) in Millions 817 984 1,133 1,253 1,380
Seq. Equity Change -17.04 % -13.13 % -9.54 % -9.24 % -8.25 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 220
Sector # 508
Overall # 3237

Return On Equity Statistics
High Average Low
56.13 %
-36.26 %
-89.46 %
(Dec 31 2020)   (Sep 30 2017)





SAGE Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Equity in Millions 1,253 1,729 2,072 945 863
Y / Y Equity Change -27.55 % -16.57 % 119.37 % 9.47 % 134.17 %
Net Income in Millions -533 -458 606 -680 -373
Y / Y Net Income Change - - - - -
Return On Equity -42.53 % -26.48 % 29.25 % -72.01 % -43.21 %





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SAGE's' Return on Equity at Yahoo Finance
SAGE's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for SAGE's Competitors
Return On Equity for Sage Therapeutics Inc 's Suppliers
Roe for SAGE's Customers




Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector ROE


Date modified: 2023-11-08T19:25:43+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com